Constipation Clinical Trial
Official title:
A Randomized Controlled Trial of Perineal Self-Acupressure for Chronic Constipation
| NCT number | NCT01867944 |
| Other study ID # | 13-000738 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | May 29, 2013 |
| Last updated | November 23, 2016 |
| Start date | June 2013 |
The primary aim of this study is to test a non-medicinal technique for chronic constipation.
The core of the technique is to have subjects repeatedly press on and massage their perineum
before defecation to fragment and soften the stool before it passes the lower rectum and
anus. The technique will be evaluated as a complementary treatment to standard treatment of
constipation (patient educational materials about treatments such as stool softeners,
laxatives fiber supplements, and increased exercise). Although this technique has been
studied for other conditions (for example in pregnant women to prevent birthing-related
injuries), and it is recommended anecdotally by some physicians, this would be the first
time it will be studied for chronic constipation in a randomized, controlled clinical trial.
$50 dollars in compensation is provided for about an hour of participant's time.
| Status | Completed |
| Enrollment | 100 |
| Est. completion date | |
| Est. primary completion date | June 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Must have experienced the following symptoms for at least three months: - Straining during at least 25 percent of defecations - Lumpy or hard stools in at least 25 percent of defecations - Sensation of incomplete evacuation for at least 25 percent of defecations - Sensation of anorectal obstruction/blockage for at least 25 percent of defecations - Manual maneuvers to facilitate at least 25 percent of defecations (eg, digital evacuation, support of the pelvic floor) - Fewer than three defecations per week - Must have experienced one or more of those symptoms at least six months ago. Exclusion Criteria: - Younger than 18 years old. - Pregnant women. - Significant weight loss (more than 10% of usual body weight in the preceding 6 months). - History of blood mixed in stool. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | UCLA Center for East-West Medicine | Los Angeles | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, Los Angeles | Yale University |
United States,
Abbott R, Ayres I, Hui E, Hui KK. Effect of perineal self-acupressure on constipation: a randomized controlled trial. J Gen Intern Med. 2015 Apr;30(4):434-9. doi: 10.1007/s11606-014-3084-6. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Technique and Educational Material Effectiveness | Unique questions regarding use of and effectiveness of technique and educational materials. | 1 month | No |
| Primary | Patient Assessment of Constipation Quality of Life Questionnaire | Constipation related health-related quality of life by means of Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL). | 1 month | No |
| Secondary | Modified Bowel Function Index and Hemorrhoid Questionnaire | A modified version of the bowel function index for patient self-completion, as well as original questions to measure change in hemorrhoid impact | 1 month | No |
| Secondary | SF-12 | Questions regarding health related quality of life (HRQOL) from the Short Form (12) Health Survey version 2 questionnaire (SF-12v2). | 1 month | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
| Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
| Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
| Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
| Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
| Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
| Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
| Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
| Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
| Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
| Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
| Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
| Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
| Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
| Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
| Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
| Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
| Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 |